COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 6,458.00
+14.00 (0.22%)
Aug 21, 2026, 3:30 PM JST
COSMOS Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Net Income | 32,046 | 42,372 | 33,719 | 32,773 | 33,048 |
Depreciation & Amortization | 24,576 | 22,229 | 19,924 | 17,368 | 15,110 |
Loss (Gain) From Sale of Assets | 231 | 508 | 937 | 113 | -195 |
Asset Writedown & Restructuring Costs | 188 | - | - | - | - |
Other Operating Activities | -2,682 | -9,586 | -8,646 | -9,034 | -13,188 |
Change in Accounts Receivable | -128 | -123 | -185 | -254 | -97 |
Change in Inventory | -6,730 | -6,182 | -8,704 | -11,156 | -5,853 |
Change in Accounts Payable | 18,670 | -2,423 | 17,697 | 22,627 | 6,183 |
Change in Other Net Operating Assets | -7,381 | 5,672 | 433 | 1,997 | -2,814 |
Operating Cash Flow | 58,790 | 52,467 | 55,175 | 54,434 | 32,194 |
Operating Cash Flow Growth | 12.05% | -4.91% | 1.36% | 69.08% | 15.49% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Capital Expenditures | -70,462 | -53,326 | -55,810 | -46,636 | -43,497 |
Sale of Property, Plant & Equipment | 296 | - | 718 | 46 | 1,519 |
Investment in Securities | -8,100 | - | - | - | - |
Other Investing Activities | -3,637 | -2,122 | -2,237 | -2,523 | -1,739 |
Investing Cash Flow | -81,903 | -55,448 | -57,329 | -49,113 | -43,717 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Long-Term Debt Issued | 34,300 | 20,000 | 18,400 | 10,000 | 300 |
Long-Term Debt Repaid | -9,042 | -5,082 | -3,193 | -1,628 | -1,486 |
Net Debt Issued (Repaid) | 25,258 | 14,918 | 15,207 | 8,372 | -1,186 |
Repurchase of Common Stock | - | -2 | - | - | -2 |
Common Dividends Paid | -5,942 | -4,959 | -4,659 | -3,266 | -3,266 |
Other Financing Activities | -1 | -2,240 | -2,021 | -1,861 | -1,768 |
Financing Cash Flow | 19,315 | 7,717 | 8,527 | 3,245 | -6,222 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Miscellaneous Cash Flow Adjustments | 1 | - | - | - | - |
Net Cash Flow | -3,797 | 4,736 | 6,373 | 8,566 | -17,745 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | -11,672 | -859 | -635 | 7,798 | -11,303 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -1.06% | -0.08% | -0.07% | 0.94% | -1.50% |
Free Cash Flow Per Share | -147.27 | -10.84 | -8.01 | 98.46 | -142.72 |
Levered Free Cash Flow | -18,189 | -6,530 | -7,985 | 5,044 | -15,323 |
Unlevered Free Cash Flow | -17,826 | -6,372 | -7,923 | 5,076 | -15,291 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash Interest Paid | 588 | 258 | 101 | 51 | 52 |
Cash Income Tax Paid | 13,018 | 9,571 | 8,993 | 9,111 | 13,337 |
Change in Working Capital | 4,431 | -3,056 | 9,241 | 13,214 | -2,581 |